SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 1

Preoperative Localization Studies in Primary Hyperparathyroidism

Mehmet ULUDAĞ
Pages
7–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this study was to evaluate preoperative localization studies used in cases of pHPT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary hyperparathyroidism (pHPT) is the third most frequently seen endocrine disease and it is the most common cause ofhypercalcemia seen in ambulatory patients.
📊
Key Findings & Data:PHPT is most often (80%-85%) caused by a single parathyroid adenoma, followedby double adenoma (4%-5%), multiple gland hyperplasia (10%-15%), and parathyroid carcinoma (<1%).
💡
Conclusion & Impact:The aim of this study was to evaluate preoperative localization studies used in cases of pHPT.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Primary hyperparathyroidism (pHPT) is the third most frequently seen endocrine disease and it is the most common cause ofhypercalcemia seen in ambulatory patients. PHPT is most often (80%-85%) caused by a single parathyroid adenoma, followedby double adenoma (4%-5%), multiple gland hyperplasia (10%-15%), and parathyroid carcinoma (<1%). The diagnosis of pHPTis biochemically established and the only curative treatment is surgery. Since the cause of pHPT is typically single-gland disease,it is possible to determine the majority of pathological glands with preoperative localization methods and use the minimallyinvasive parathyroidectomy (MIP) approach. MIP has become the standard treatment for pHPT in selected patients. There areboth noninvasive and invasive preoperative localization methods. Noninvasive methods currently used include ultrasonography(US), parathyroid scintigraphy, 4-dimensional computed tomography (CT), magnetic resonance imaging, and positron emissiontomography-CT with 18F-fluoroquinolone and 11C-methionine. Preoperative invasive localization methods include parathyroidhormone (PTH) measurement with fine-needle aspiration biopsy, lateralization with PTH measurement via bilateral jugular veinsampling, selective venous sampling, and parathyroid arteriography. The aim of this study was to evaluate preoperative localization studies used in cases of pHPT.

🔖

Cite This Article

ULUDAĞ, M. (2019). Preoperative Localization Studies in Primary Hyperparathyroidism. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 1, 7–15. https://ajindex.com/articles/363419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Walker MD, Bilezikian JP. Primary hyperparathyroidism: recent advances. Curr Opin Rheumatol 2018;30:427–39
  2. Uludag M, Aygun N. Primary Hyperparathyroidism: Current Situation in the Clinical and Biochemical Presentation. Med Bull Sisli Etfal Hosp 2016;50:171–80
  3. Mallick R, Chen H. Diagnosis and Management of Hyperparathyroidism. Adv Surg 2018;52:137–53
  4. Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am 2010;43:417–32
  5. Callender GG, Udelsman R. Surgery for primary hyperparathyroidism. Cancer 2014;120:3602–16
  6. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014;99:3561–9
  7. Wu JX, Yeh MW. Asymptomatic Primary Hyperparathyroidism: Diagnostic Pitfalls and Surgical Intervention. Surg Oncol Clin N Am 2016;25:77–90
  8. Egan RJ, Scott-Coombes DM. The surgical management of sporadic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 2018;32:847–59
  9. Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Clinical review: Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab 2013;98:902–12
  10. Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 2016;151:959–68
  11. Gallagher SF, Denham DW, Murr MM, Norman JG. The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism. Surgery 2003;134:910–7
  12. Arima M, Yokoi H, Sonoda T. Preoperative identification of tumor of the parathyroid by ultrasonotomography. Surg Gynecol Obstet 1975;141:242–4
  13. Liddy S, Worsley D, Torreggiani W, Feeney J. Preoperative Imaging in Primary Hyperparathyroidism: Literature Review and Recommendations. Can Assoc Radiol J 2017;68:47–55
  14. Bunch PM, Kelly HR. Preoperative Imaging Techniques in Primary Hyperparathyroidism: A Review. JAMA Otolaryngol Head Neck Surg 2018;144:929–37
  15. Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 2012;19:577–83
  16. Agha A, Hornung M, Schlitt HJ, Stroszczynski C, Jung EM. The role of contrast-enhancend ultrasonography (CEUS) in comparison with 99mTechnetium-sestamibi scintigra